Table 3.
Domain | Control subjects (N = 21) | pSS with FC <50 μg/g (N = 25) | pSS with FC >50 μg/g (N = 25) |
---|---|---|---|
Abdominal pain | 97 | 87a | 88b |
Diarrhoea | 100 | 94b | 91b |
Constipation | 96 | 78a | 80a |
Bloating and flatulence | 90 | 77a | 61b |
Vomiting and nausea | 100 | 97b | 97b |
Psychological well-being | 93 | 72b | 89 |
Influence on daily life | 99 | 94a | 68b |
Average | 93 | 82a | 78b |
FC faecal calprotectin, pSS primary Sjögren’s syndrome
Values are given as medians in millimetres, and higher values indicate less symptoms. Mann–Whitney U test was used to compare groups. Significant differences were identified between control subjects in comparison with both pSS groups. No significant differences were identified between patients with pSS with and without pathological FC testing
a p < 0.05 compared with control subjects
b p < 0.01 compared with control subjects